Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q4 2021 call → NOWe need to determine if management explains the company's business direction by narrating what its counterparties are themselves doing and scaling. The key is whether management's forward account is substantially about the growth, expansion, ramp, adoption, or program build-out of specific customers, partners, etc., that the company already supplies or serves, and that this is early and large relative to the company. Let's review the transcript. The call discusses strategic objectives, loan growth, digital banking, merger disruption, etc. The main forward-looking elements: loan pipeline, merger disruption (adding people from merging institutions), digital initiatives (Bitcoin, overdraft fees), floating-rate assets, rising rates. The "counterparties" here could be the merging institutions? But those are not customers; they are competitors or sources of hires. The company is not supplying them. The Bitcoin partnership with NYDIG is a partner, but the discussion is about enabling customers to transact Bitcoin, not about NYDIG's own expansion. The small business lending platform is about automating. There is no narration of a specific customer's or partner's own growth trajectory as the driver of the company's coming volume. The loan pipeline is described as strong, but that's about demand from borrowers generally, not about specific counterparties' own scaling. The merger disruption is about hiring people from merging banks, not about serving those banks. So no. Thus answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.